Related Experiment Video
Updated: May 3, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Kidney Dysfunction in Heart Failure: Core Curriculum 2025
Kevin Bryan Lo1, Arun Janakiraman2, Janani Rangaswami3
1Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Heart failure (HF) and kidney dysfunction involve harmful bidirectional pathways. Optimizing decongestion and guideline-directed therapies is crucial for improving outcomes in these high-risk patients.
Area of Science:
- Cardiology
- Nephrology
- Translational Medicine
Background:
- Heart failure (HF) and kidney dysfunction share complex, bidirectional pathophysiological pathways.
- Suboptimal management, including poor decongestion and underutilization of guideline-directed medical therapy (GDMT), exacerbates poor cardiovascular and kidney outcomes in patients with coexisting HF and kidney dysfunction.
- Diuretic resistance is a significant challenge, contributing to persistent congestion and adverse events.
Purpose of the Study:
- To highlight the interconnected pathophysiology of heart failure and kidney dysfunction.
- To emphasize the importance of optimizing decongestion strategies and guideline-directed medical therapies in this patient population.
- To underscore the need for integrated management approaches to improve patient outcomes.
Main Methods:
- Review of current understanding of the pathophysiology linking heart failure and kidney dysfunction.
- Analysis of the impact of suboptimal decongestion and diuretic resistance on patient outcomes.
- Evaluation of the role and benefits of guideline-directed medical therapies in managing patients with comorbid HF and kidney dysfunction.
Main Results:
- Bidirectional organ dysfunction significantly worsens prognosis in patients with heart failure and kidney dysfunction.
- Effective decongestion and management of diuretic resistance are critical for mitigating adverse events.
- Guideline-directed medical therapies demonstrate efficacy in reducing mortality, hospitalizations, and kidney function decline, while improving quality of life.
Conclusions:
- Integrated and personalized strategies for decongestion are essential for managing patients with heart failure and kidney dysfunction.
- Optimizing the implementation of evidence-based therapies is key to modifying the disease trajectory and reducing adverse outcomes.
- Addressing the interplay between heart failure and kidney dysfunction requires a combined approach to improve survival and quality of life in this high-risk group.
More Related Videos
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions